Blood thinner response in people with high Lp(a)
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at how well two common blood thinners (aspirin and clopidogrel) work in people with high levels of Lp(a), a type of fat in the blood linked to heart disease. It may help doctors understand if these people need different treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a blood test showing high lipoprotein(a) — a fat-like substance in your blood (125 nmol/L or higher).
- You have not had a heart attack, stroke, or other heart-related emergency in the last 3 months.
- You are not currently taking blood thinners like aspirin, clopidogrel, or other anticoagulants.
- You do not have a bleeding disorder, active bleeding, or high risk of bleeding.
- You are not allergic to aspirin or clopidogrel, and you do not have an active stomach ulcer or recent stomach bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a type of fat in the blood called lipoprotein(a) and your body's ability to break down clots affect heart disease or heart valve disease. It is for people who are already taking certain cholesterol-lowering medicines or have severe aortic valve narrowing from calcium buildup.
This study looks at how blood-thinning medications (like aspirin and clopidogrel) work in people with hardened arteries or peripheral artery disease (PAD). By understanding this, doctors hope to improve treatment and prevent heart attacks and strokes.
This study follows people who receive a stent to open a blocked heart artery and checks how well their blood-thinning medicine works using a simple blood test. The goal is to learn more about the best ways to prevent blood clots in similar patients.
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
This study looks at whether a type of fat in your blood, called lipoprotein(a), can help predict how well you do after a planned procedure to open a blocked heart artery. If you join, we will take a blood sample before the procedure and follow your recovery to see how lipoprotein(a) levels relate to outcomes.
This study tests an investigational medicine given by injection to lower Lp(a), a type of fat linked to heart disease. It may help people with high Lp(a) who already have heart problems or are at increased risk.
Hear when a new Cardiovascular Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.